Roberts, Glore & Co’s Cardinal Health CAH Stock Holding History

Roberts, Glore & Co’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$249K	Hold	1,178	–	–	0.07%	189
2025 Q4	$242K	Buy	+1,178	New	+$222K	0.06%	194

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Roberts, Glore & Co's CAH Position: Q1 2026 in Review

Roberts, Glore & Co held its Cardinal Health (CAH) position steady in Q1 2026 at 1,178 shares worth $249K. The position accounts for 0.07% of the portfolio, ranked #189.

Roberts, Glore & Co first reported a position in CAH in Q4 2025 and has held it in 2 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

Roberts, Glore & Co held 1,178 shares of Cardinal Health worth $249K as of Q1 2026.
Roberts, Glore & Co left its Cardinal Health share count unchanged in Q1 2026.
Cardinal Health made up 0.07% of Roberts, Glore & Co's portfolio in Q1 2026, its #189 holding.
Roberts, Glore & Co first reported a position in Cardinal Health in Q4 2025 and has held it in 2 quarters since.
1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Roberts, Glore & Co's 13F filing for Q1 2026, filed 4 May 2026.